Viridian Therapeutics, Inc. · NASDAQ:VRDN

Fairmount Funds Management LLC reported a 14.04% stake in Viridian Therapeutics, Inc. (Schedule 13D/A)

Event May 11, 2026 · Filed May 13, 2026

Fairmount Funds Management LLC reported a 14.04% stake in Viridian Therapeutics, Inc., 17,201,800 shares, with active intent on May 11, 2026. Filed May 13, 2026 (Schedule 13D/A).

Stake
14.04%
Shares
17,201,800
Intent
Active
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Fairmount Funds Management LLC14.04%17,201,800
Fairmount Healthcare Fund II GP LLC14.04%17,201,800

Source

View original at SEC

Related